(PharmaNewsWire.Com, July 10, 2017 ) Kidney cancer accounts for 3% of all human cancers and is the most frequently occurring urologic tumours. Diagnosis of this cancer is generally done by blood and urine tests, imaging tests(like CT, MRI, PET scan and ultrasound) and biopsies. Treatment options include surgery, targeted therapy, immunotherapy, chemotherapy and ablation.
High-intensity focused ultrasound (HIFU) is a fairly new technique which involves pointing very focused ultrasound beams from outside the body to destroy the tumour. Small kidney cancers can be treated by Ablation with cryotherapy or Radiofrequency Ablation (RFA). Research is still underway in these techniques to determine their long term usage as well as to refine them.
The DROC Analysis contains some of the factors that have major effects on the market dynamics be it positive or negative. Few factors analysed in the section are rising aging population, changes in lifestyle such as increased intake of alcohol and disproportionate smoking, and government policies to provide better care for kidney Cancer. However, high treatment cost is one of the main factor hampering the growth of the market in this region.
The market is segmented based on type and tests and is studied for a deep-level understanding of the Kidney Cancer Diagnostics and Therapeutics market. Each sub segment is accompanied with Market Size Estimations and Y-o-Y Forecasts as well.
1) By Type • Transitional Cell Cancer • Renal cell carcinoma • Renal sarcoma • Other Cancers
2) By Tests a. Biopsy b. CT Scan c. Cystoscopy d. Intravenous pyelogram e. Kidney Ultrasound
North American Market is studied in geographic perspective by segregating the market shares between USA and Canada. The North America market is advanced and is focused on inventing cost-effective techniques. Companies are dedicated to research, sourcing, and quality, factors that are vital to the success of the industry.
As per the report,the major companies dominating the Kidney Cancer Diagnostics and Therapeutics market in this region are GlaxoSmithKline, Bayer, Pfizer, Sanofi S.A, Hoffmann La Roche, Novartis, Abbott Laboratories.
Scope of the North America Kidney Cancer Diagnostics and TherapeuticsMarket: • Regional and country-level analysis that provides an innate perspective of USA and Canada Market to that of the North American region • To detect major focus areas of industrial growth Segment-level analysis on basis of type, therapeutics, end-user along with market size forecasts and y-o-y estimations are provided • Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics • PESTLE and Porter’s Five Forces Analyses that examine the macro& micro environmental factors such as political influence, technological prowess, industry rivalry to name a few. • An extensive listing of major market playersalong with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and analyst overview to study and sustain the market environment • mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies all rolled out into Competitive landscape • Expertly devised Market Outlook comprising theInvestment opportunitiesto provide both individuals and organizations a strong financial foothold in the market
About Market Data Forecast: The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
